Clinical Trial Update: Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pentoxifylline versus a probiotic for necrotizing enterocolitis in preterm neonates has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Drugs mentioned

• Pentoxifylline (pentoxifylline)
• Probiotic (probiotic)

Snippet

Sponsor: Tanta University | Conditions: Necrotizing Enterocolitis | Phase 3 | Status: COMPLETED